R&D | December 05, 2025
Peapod Bio teams up with Enamine to supercharge drug discovery
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
The company says the innovation delivers stronger moisture protection for highly sensitive drug molecules
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Subscribe To Our Newsletter & Stay Updated
